Stockholm, Sweden and Tonghua, China - July 6, 2010 - Swedish Orphan Biovitrum (STO: SOBI) and Dongbao today announced their intent to form a strategic Commercial Alliance.  In such an alliance, Swedish Orphan Biovitrum would be the marketing and sales partner of choice for Dongbao’s pipeline of Biopharmaceuticals and other drugs in Europe and Dongbao would be the marketing and sales partner of choice for Swedish Orphan Biovitrum’s marketed and pipeline products in China.

For the whole press release please visit www.sobi.com.